Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasmacytoid dendritic cell | 10 studies | 29% ± 7% | |
classical monocyte | 7 studies | 23% ± 7% | |
non-classical monocyte | 7 studies | 28% ± 8% | |
regulatory T cell | 6 studies | 26% ± 14% | |
macrophage | 3 studies | 19% ± 5% | |
conventional dendritic cell | 3 studies | 32% ± 13% | |
mast cell | 3 studies | 21% ± 7% | |
monocyte | 3 studies | 20% ± 5% | |
dendritic cell | 3 studies | 34% ± 8% |
Insufficient scRNA-seq data for expression of MIIP at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 2772.05 | 180 / 180 | 100% | 46.23 | 430 / 430 |
uterus | 100% | 2451.85 | 170 / 170 | 100% | 49.09 | 459 / 459 |
thymus | 100% | 2170.29 | 653 / 653 | 100% | 44.72 | 604 / 605 |
brain | 100% | 1443.52 | 2634 / 2642 | 100% | 57.47 | 705 / 705 |
esophagus | 100% | 1448.45 | 1444 / 1445 | 99% | 24.27 | 182 / 183 |
intestine | 100% | 1717.23 | 966 / 966 | 99% | 32.05 | 523 / 527 |
prostate | 100% | 1962.27 | 245 / 245 | 99% | 31.82 | 498 / 502 |
skin | 100% | 1364.92 | 1808 / 1809 | 99% | 43.48 | 467 / 472 |
lung | 100% | 2329.19 | 578 / 578 | 99% | 31.72 | 1140 / 1155 |
bladder | 100% | 1944.14 | 21 / 21 | 99% | 43.83 | 497 / 504 |
breast | 100% | 1783.78 | 459 / 459 | 98% | 27.40 | 1098 / 1118 |
stomach | 99% | 1176.76 | 357 / 359 | 99% | 29.41 | 282 / 286 |
liver | 100% | 1098.65 | 226 / 226 | 98% | 24.51 | 397 / 406 |
pancreas | 98% | 1074.38 | 322 / 328 | 99% | 31.03 | 177 / 178 |
adrenal gland | 100% | 1094.98 | 258 / 258 | 94% | 14.64 | 217 / 230 |
kidney | 100% | 1359.06 | 89 / 89 | 90% | 14.67 | 810 / 901 |
adipose | 100% | 1793.62 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 28.94 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 92.81 | 29 / 29 |
peripheral blood | 100% | 4091.38 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 3501.68 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 37.21 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 65.11 | 1 / 1 |
blood vessel | 100% | 1567.54 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1359.64 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 1034.13 | 838 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0005515 | Molecular function | protein binding |
Gene name | MIIP |
Protein name | Migration and invasion-inhibitory protein (IGFBP2-binding protein) (Invasion-inhibitory protein 45) (IIp45) |
Synonyms | IIP45 |
Description | FUNCTION: Inhibits glioma cells invasion and down-regulates adhesion- and motility-associated genes such as NFKB2 and ICAM1. Exhibits opposing effects to IGFBP2 on cell invasion. . |
Accessions | ENST00000235332.6 [Q5JXC2-1] Q5JXC2 |